Pregnancy and risk of COVID-19: a Norwegian registry-linkage study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
01 2022
Historique:
revised: 14 09 2021
received: 17 04 2021
accepted: 10 10 2021
pubmed: 18 10 2021
medline: 14 1 2022
entrez: 17 10 2021
Statut: ppublish

Résumé

To compare the risk of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and contact with specialist healthcare services for coronavirus disease 2019 (COVID-19) between pregnant and non-pregnant women. All women ages 15-45 living in Norway on 1 March 2020 (n = 1 033 699). We linked information from the national birth, patient, communicable diseases and education databases using unique national identifiers. We estimated hazard ratios (HR) among pregnant compared to non-pregnant women of having a positive test for SARS-CoV-2, a diagnosis of COVID-19 in specialist healthcare, or hospitalisation with COVID-19 using Cox regression. Multivariable analyses adjusted for age, marital status, education, income, country of birth and underlying medical conditions. Pregnant women were not more likely to be tested for or to a have a positive SARS-CoV-2 test (adjusted HR 0.99; 95% CI 0.92-1.07). Pregnant women had higher risk of hospitalisation with COVID-19 (HR 4.70, 95% CI 3.51-6.30) and any type of specialist care for COVID-19 (HR 3.46, 95% CI 2.89-4.14). Pregnant women born outside Scandinavia were less likely to be tested, and at higher risk of a positive test (HR 2.37, 95% CI 2.51-8.87). Compared with pregnant Scandinavian-born women, pregnant women with minority background had a higher risk of hospitalisation with COVID-19 (HR 4.72, 95% CI 2.51-8.87). Pregnant women were not more likely to be infected with SARS-CoV-2. Still, pregnant women with COVID-19, especially those born outside of Scandinavia, were more likely to be hospitalised. Pregnant women are at increased risk of hospitalisation for COVID-19.

Identifiants

pubmed: 34657368
doi: 10.1111/1471-0528.16969
pmc: PMC8652518
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-109

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105545
Pays : United Kingdom
Organisme : Norges Forskningsråd
ID : 262700

Informations de copyright

© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647
pubmed: 33151921
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Br J Psychiatry. 2021 Sep;219(3):501-506
pubmed: 33448259
MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-1354
pubmed: 32970655
BJOG. 2022 Jan;129(1):101-109
pubmed: 34657368
Am J Obstet Gynecol. 2021 May;224(5):484-495
pubmed: 33529575
JAMA. 2021 Mar 16;325(11):1027-1028
pubmed: 33625462
Rev Med Virol. 2021 Sep;31(5):1-16
pubmed: 33387448
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1635-1640
pubmed: 33151917
Epidemiology. 1991 Jan;2(1):33-9
pubmed: 2021664
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775
pubmed: 32584795
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
Am J Obstet Gynecol. 2021 May;224(5):479-483
pubmed: 33539824
JAMA Netw Open. 2020 Nov 2;3(11):e2029256
pubmed: 33211113
Scand J Public Health. 2020 Feb;48(1):49-55
pubmed: 31288711
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33444286
Am J Obstet Gynecol. 2021 May;224(5):510.e1-510.e12
pubmed: 33221292
New Microbes New Infect. 2021 May;41:100849
pubmed: 33614041
J Racial Ethn Health Disparities. 2021 Dec;8(6):1563-1572
pubmed: 33180278

Auteurs

M C Magnus (MC)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.

L Oakley (L)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

H K Gjessing (HK)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

O Stephansson (O)

Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Women's Health, Karolinska University Hospital, Solna, Stockholm, Sweden.

H M Engjom (HM)

Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway.
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.

F Macsali (F)

Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway.
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.

P B Juliusson (PB)

Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.

A-M Nybo Andersen (AM)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

S E Håberg (SE)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH